NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=140443&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements, leading to potential legal consequences and financial repercussions for the company [1]. Allegations Summary - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the allegations is from March 13, 2023, to March 11, 2025 [1]. - Shareholders are encouraged to register for the class action by May 19, 2025, to participate in potential recovery [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

ZYXI Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO , April 2, 2025 /PRNewswire/ -- A securities class action has been filed against Zynex, Inc. (NASDAQ: ZYXI), a medical device manufacturer that produces and markets electrotherapy devices for use in pain management and physical rehabilitation, after it reported dismal Q4 and FY 2024 financial results which sent the price of Zynex shares down $3.59 (-51%) on March 12, 2025. The suit, captioned Tuncel v. Zynex, Inc., et al., No. 1:25-cv-00 ...

ZYXI investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the l ...

NEW YORK, April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-f ...

Core Viewpoint - A class action has been filed against Zynex, Inc. for allegedly inflating its revenue and filing false claims, leading to significant financial repercussions for the company and its shareholders [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that Zynex shipped products in excess of need, resulting in inflated revenue [2]. - The company faced scrutiny from insurers, including Tricare, due to its practice of filing false claims [2]. - On March 11, 2025, Zynex reported a significant revenue shortfall attributed to slower payments from certain payers, leading to a 51.3% drop in stock price, closing at $3.41 per share [3]. Group 2: Class Action Participation - Shareholders may be eligible to participate in the class action against Zynex, with a deadline to file as lead plaintiff by May 19, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Group 3: Company Background - Zynex, Inc. is a medical device manufacturer specializing in electrotherapy devices for pain management and physical rehabilitation [1].

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139462&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

CLASS PERIOD: March 13, 2023 to March 11, 2025 NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139422& ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, March 28, 2025 /PRNewswire/ -- F ...

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. alleging securities fraud that affected investors between March 13, 2023, and March 11, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2]. - It is alleged that the company's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2]. - The lawsuit suggests that Zynex is likely to face adverse consequences, such as removal from insurer networks and federal penalties, due to these practices [2]. - Defendants' positive statements regarding the company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the specified timeframe have until May 19, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].